The story has been updated to clarify language about Cancer Genetics' review of its operations.
NEW YORK (GenomeWeb) – At least two class action lawsuits have been filed against Cancer Genetics alleging the company made false and/or misleading statements and/or failed to disclose information pertinent to investors.